Search

everythinglearnresearchcommunity

for

Search:↓

The arrector pili muscle attaches to the extracellular matrix using α5β1 integrin and connects muscle cells using α1β1 integrin.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

JAK inhibitors are effective and safe for treating severe alopecia areata.

A 28-year-old man with type 1 diabetes had skin and hair issues due to zinc deficiency.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

An infant with a zinc deficiency skin disorder improved with zinc treatment.

Inflammation damages sweat ducts, causing sweat gland injury.

A one-year-old child with a genetic condition had symptoms improved by treating zinc deficiency.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Timely zinc treatment is crucial for preventing severe complications in Acrodermatitis enteropathica.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

CLE40 and CRN/CLV2 pathways have opposite effects on root growth in Arabidopsis.

CCCA can affect both genders and all ages, and it has a genetic component.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Targeting the AhR pathway may help treat alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Arabidopsis PCaP2 helps plants survive drought by linking ABA and SA signals.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.